通过构建重组复合表位免疫原，研究其免疫学活性，为研制HCV治疗性疫苗奠定基础。
In order to pave the way for developing HCV therapeutic vaccines, we construct the recombinant polyepitope antigen and study the immunity of it in vitro and in vivo.
目的为了克服灭活口蹄疫病毒疫苗可能存在的传播病毒的潜在危险，构建一种能预防O型口蹄疫病毒感染的VP1表位重组蛋白疫苗。
Objective to developed a recombinant protein vaccine with epitopes on VP1 protein for prevention of foot-and-mouth disease virus (FMDV) spreading by inactive-FMD vaccine.
应用推荐